Bastide Le Confort Médical : Increase of volatility
| Entry price | Target | Stop-loss | Potential |
|---|
|
€23.91 |
€27.9 |
€21.9 |
+16.69% |
|---|
Bastide, Le Confort Med. shares have been in strong demand lately. The technical chart pattern looks positive which may give rise to new gains.
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● The company has solid fundamentals for a short-term investment strategy.
● Considering the small differences between the analysts' various estimates, the group's business visibility is good.
● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
● Within the weekly time frame the stock shows a bullish technical configuration above the support level at 19.95 EUR
● Stock prices approach a strong long-term resistance in weekly data at EUR 23.35.
● The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
● The group usually releases earnings worse than estimated.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
BASTIDE LE CONFORT MÉDICAL 
